Page last updated: 2024-09-05

erlotinib hydrochloride and Experimental Hepatoma

erlotinib hydrochloride has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmad, NB; Bian, CB; Deshmukh, M; El-Abtah, M; Fuchs, BC; Fujiwara, N; Goossens, N; Higashi, T; Hirschfield, H; Hoshida, H; Hoshida, Y; Koh, AP; Lujambio, A; Nakagawa, S; Ono, A; Poelstra, K; Prakash, J; Ruiz de Galarreta, M; Sanchez, R; Venkatesh, A; Vincek, A	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Experimental Hepatoma

Article	Year
Cell type-specific pharmacological kinase inhibition for cancer chemoprevention. Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:2 Topics: Animals; Apoptosis; Cell Proliferation; Drug Delivery Systems; ErbB Receptors; Erlotinib Hydrochloride; Hepatocytes; Humans; Liver Cirrhosis; Liver Neoplasms, Experimental; Male; Mice, Inbred C57BL; Myofibroblasts; Protein Kinase Inhibitors; Rats; Rats, Wistar	2018

Article

Year

Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.

Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:2

Topics: Animals; Apoptosis; Cell Proliferation; Drug Delivery Systems; ErbB Receptors; Erlotinib Hydrochloride; Hepatocytes; Humans; Liver Cirrhosis; Liver Neoplasms, Experimental; Male; Mice, Inbred C57BL; Myofibroblasts; Protein Kinase Inhibitors; Rats; Rats, Wistar

2018